作者: Feng Jin
DOI: 10.1007/978-1-4419-5955-3_12
关键词:
摘要: Population-based pharmacokinetic-pharmacodynamic (PK-PD) approaches have been successfully applied in various stages of drug development over the last few decades. The antibody-based therapeutics has benefited substantially from utilization population approaches. Moreover, almost all FDA-approved monoclonal antibody evaluated using In this chapter, application PK-PD methods will be reviewed context translational strategies employed during therapeutics.